Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
NovoCure Limited - Ordinary Shares
(NQ:
NVCR
)
13.75
-1.24 (-8.27%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,495,821
Open
13.25
Bid (Size)
13.56 (400)
Ask (Size)
13.76 (700)
Prev. Close
14.99
Today's Range
11.80 - 13.94
52wk Range
9.820 - 22.30
Shares Outstanding
103,647,871
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
NovoCure (NVCR) Q4 2025 Earnings Call Transcript
↗
Today 13:37 EST
NovoCure (NVCR) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
World Trade
Novocure Ltd (NASDAQ:NVCR) Reports Mixed Q4 2025 Results, Stock Falls on Revenue Miss
↗
Today 9:41 EST
Via
Chartmill
Performance
YTD
+4.8%
+4.8%
1 Month
+3.7%
+3.7%
3 Month
+7.8%
+7.8%
6 Month
+15.4%
+15.4%
1 Year
-34.5%
-34.5%
More News
Read More
Novocure Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update
Today 7:00 EST
From
Novocure
Via
Business Wire
The market is filled with gapping stocks in Wednesday's session.
↗
February 25, 2026
Via
Chartmill
Tumor Treating Fields (TTFields) Therapy to be Covered for Patients with Newly Diagnosed Glioblastoma Through British Columbia Cancer (BC Cancer)
February 24, 2026
From
Novocure
Via
Business Wire
Soleus Adds a Significant Number of Celcuity Shares
↗
February 13, 2026
Via
The Motley Fool
AI: The Great Disruptor or the Great Divider?
↗
February 13, 2026
Via
Chartmill
NVCR Rallies On FDA Approval For Cancer Treatment Device, Analyst Still Sees 275% Potential Upside
↗
February 12, 2026
Via
Stocktwits
Topics
Government
Which stocks are experiencing notable movement on Thursday?
↗
February 12, 2026
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
February 12, 2026
Via
Chartmill
The Bioelectronic Frontier: A Deep-Dive into NovoCure’s Multi-Indication Transformation
February 12, 2026
Via
Finterra
Topics
Initial Public Offering
Intellectual Property
Stay updated with the stocks that are on the move in today's pre-market session.
↗
February 12, 2026
Via
Chartmill
Nasdaq, S&P 500 Futures Rise, Markets Await Jobless Claims: Why NVDA, META, NKTR, NVCR, AMAT, ASTS Are On Traders' Radar Today
↗
February 12, 2026
Via
Stocktwits
Topics
Stocks
Novocure Stock Surges Nearly 30% After Hours: FDA Clears First New Pancreatic Cancer Therapy In Almost Three Decades
↗
February 12, 2026
Via
Stocktwits
U.S. FDA Approves Novocure’s Optune Pax® for the Treatment of Locally Advanced Pancreatic Cancer
February 11, 2026
From
Novocure
Via
Business Wire
Novocure Announces Preliminary Full Year and Fourth Quarter 2025 Performance and Provides Company Update
January 12, 2026
From
Novocure
Via
Business Wire
NovoCure (NVCR) Q4 2024 Earnings Call Transcript
↗
December 23, 2025
Via
The Motley Fool
Topics
Earnings
NovoCure (NVCR) Q3 2024 Earnings Call Transcript
↗
December 23, 2025
Via
The Motley Fool
Topics
Earnings
Novocure (NVCR) Q2 2025 Earnings Call Transcript
↗
December 23, 2025
Via
The Motley Fool
Topics
Earnings
Novocure to Present at 44th Annual J.P. Morgan Healthcare Conference
December 22, 2025
From
Novocure
Via
Business Wire
Novocure Appoints Company President Frank Leonard as Chief Executive Officer
December 01, 2025
From
Novocure
Via
Business Wire
NovoCure (NVCR) Q3 2025 Earnings Call Transcript
↗
November 27, 2025
Via
The Motley Fool
Topics
Earnings
World Trade
Novocure to Participate in 37th Annual Piper Sandler Healthcare Conference
November 26, 2025
From
Novocure
Via
Business Wire
2 Healthcare Stocks for Individual Investors With a 40-Year Time Horizon
↗
November 12, 2025
Via
The Motley Fool
Novocure to Participate in 2025 Jefferies Global Healthcare Conference
November 12, 2025
From
Novocure
Via
Business Wire
Frequently Asked Questions
Is NovoCure Limited - Ordinary Shares publicly traded?
Yes, NovoCure Limited - Ordinary Shares is publicly traded.
What exchange does NovoCure Limited - Ordinary Shares trade on?
NovoCure Limited - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for NovoCure Limited - Ordinary Shares?
The ticker symbol for NovoCure Limited - Ordinary Shares is NVCR on the Nasdaq Stock Market
What is the current price of NovoCure Limited - Ordinary Shares?
The current price of NovoCure Limited - Ordinary Shares is 13.75
When was NovoCure Limited - Ordinary Shares last traded?
The last trade of NovoCure Limited - Ordinary Shares was at 02/26/26 04:00 PM ET
What is the market capitalization of NovoCure Limited - Ordinary Shares?
The market capitalization of NovoCure Limited - Ordinary Shares is 1.43B
How many shares of NovoCure Limited - Ordinary Shares are outstanding?
NovoCure Limited - Ordinary Shares has 1B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.